What are the diagnostic criteria for diabetic ketoacidosis in an adult and what is the step‑by‑step management protocol?

Diagnosis and Step-by-Step Management of Diabetic Ketoacidosis in Adults

Diagnostic Criteria

Diagnose DKA when all three criteria are simultaneously present: blood glucose >250 mg/dL, venous pH <7.3, and serum bicarbonate <15 mEq/L with moderate ketonuria or ketonemia 1, 2, 3. However, the glucose threshold has been de-emphasized due to increasing euglycemic DKA, particularly with SGLT2 inhibitors, pregnancy, reduced oral intake, or alcohol use 3, 4.

Essential Laboratory Workup

• Draw venous or arterial blood gas, complete metabolic panel with calculated anion gap ([Na⁺] - [Cl⁻ + HCO₃⁻], should be >10-12 mEq/L), plasma glucose, blood β-hydroxybutyrate (preferred over urine ketones), serum osmolality, BUN, creatinine, complete blood count with differential, urinalysis, and ECG 1, 2, 3.
• Obtain bacterial cultures (blood, urine, throat) if infection is suspected, as infection is the most common precipitating factor 1, 2.
• Consider additional tests if clinically indicated: chest X-ray, blood lactate, amylase, lipase, hepatic transaminases, troponin, creatine kinase 3.
• Use blood β-hydroxybutyrate measurement, not nitroprusside-based urine ketone tests, because the latter only detect acetoacetate and acetone while missing β-hydroxybutyrate—the predominant and strongest ketoacid in DKA 1, 2, 3.

Severity Classification

• Mild DKA: pH 7.25-7.30, bicarbonate 15-18 mEq/L, alert mental status 1, 3.
• Moderate DKA: pH 7.00-7.24, bicarbonate 10-15 mEq/L, drowsy mental status 1, 3.
• Severe DKA: pH <7.00, bicarbonate <10 mEq/L, stupor or coma—requires intensive monitoring including possible central venous and intra-arterial pressure monitoring 1, 2, 3.

---

Step-by-Step Management Protocol

Step 1: Immediate Fluid Resuscitation (First Hour)

Begin aggressive isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour (approximately 1-1.5 L in the first hour) to restore intravascular volume and renal perfusion 1, 2, 3. This takes priority over insulin initiation 2. The typical total body water deficit is 6-9 L 1, 2.

Step 2: Assess and Correct Potassium BEFORE Starting Insulin

Total body potassium depletion is universal in DKA (3-5 mEq/kg) even if serum potassium appears normal or elevated 1, 2, 3. Insulin therapy will drive potassium intracellularly, causing rapid decline 1, 2.

• If K⁺ <3.3 mEq/L: Hold insulin and aggressively replace potassium at 20-40 mEq/hour until K⁺ ≥3.3 mEq/L to prevent fatal arrhythmias, cardiac arrest, and respiratory muscle weakness 1, 2, 3.
• If K⁺ 3.3-5.5 mEq/L: Start insulin and add 20-30 mEq/L potassium to IV fluids (approximately 2/3 KCl and 1/3 KPO₄) once adequate urine output is confirmed 1, 2, 3.
• If K⁺ >5.5 mEq/L: Withhold potassium initially but monitor every 2-4 hours as levels will fall rapidly with insulin therapy 1, 2.
• Target serum potassium 4-5 mEq/L throughout treatment 1, 2.

Step 3: Initiate Insulin Therapy

For moderate-to-severe DKA or critically ill/mentally obtunded patients, start continuous IV regular insulin infusion at 0.1 units/kg/hour without an initial bolus 1, 2, 3. An optional IV bolus of 0.1-0.15 units/kg may be given 1, 2.

• Target glucose decline of 50-75 mg/dL per hour 1, 2.
• If glucose does not fall by ≥50 mg/dL in the first hour despite adequate hydration, double the insulin infusion rate each subsequent hour until steady decline is achieved 1, 2, 3.

Alternative for mild-to-moderate uncomplicated DKA in hemodynamically stable, alert patients: Subcutaneous rapid-acting insulin analogs (0.15 units/kg every 2-3 hours) combined with aggressive fluid management are equally effective, safer, and more cost-effective than IV insulin 1, 2.

Step 4: Ongoing Fluid Management (After First Hour)

• Calculate corrected serum sodium: Add 1.6 mEq/L for each 100 mg/dL glucose above 100 mg/dL 1, 2, 3.
• If corrected sodium is normal or elevated: Switch to 0.45% NaCl at 4-14 mL/kg/hour 1, 2, 3.
• If corrected sodium is low: Continue 0.9% NaCl at 4-14 mL/kg/hour 1, 2, 3.
• Aim to replace total fluid deficit within 24 hours while limiting change in serum osmolality to ≤3 mOsm/kg/hour to reduce cerebral edema risk 1, 2.
• Monitor closely for fluid overload in patients with cardiac or renal compromise 1, 2.

Step 5: Add Dextrose When Glucose Falls

When plasma glucose falls to 250 mg/dL, change IV fluids to 5% dextrose with 0.45-0.75% NaCl while maintaining insulin infusion 1, 2, 3. This prevents hypoglycemia and allows insulin to continue clearing ketones 1, 2. Stopping insulin when glucose normalizes is a common cause of recurrent ketoacidosis 1, 2.

Step 6: Monitoring During Treatment

• Draw blood every 2-4 hours for serum electrolytes, glucose, BUN, creatinine, calculated osmolality, venous pH, and β-hydroxybutyrate 1, 2, 3.
• Use venous pH (typically 0.03 units lower than arterial) for ongoing monitoring—repeat arterial blood gases are generally unnecessary after initial diagnosis 1, 2.
• Monitor β-hydroxybutyrate as the preferred method for tracking ketosis resolution; nitroprusside-based tests miss the predominant ketone body and may delay appropriate therapy 1, 2.

Step 7: Identify and Treat Precipitating Causes

Common precipitants include: infection (most common), myocardial infarction, cerebrovascular accident, insulin omission or inadequacy, pancreatitis, SGLT2 inhibitor use, glucocorticoid therapy, trauma, pregnancy, and alcohol abuse 1, 2, 3. Obtain bacterial cultures and start appropriate antibiotics when infection is suspected 1, 2.

Step 8: Resolution Criteria

DKA is resolved when ALL of the following are achieved:

• Glucose <200 mg/dL 1, 2
• Serum bicarbonate ≥18 mEq/L 1, 2
• Venous pH >7.3 1, 2
• Anion gap ≤12 mEq/L 1, 2

Continue insulin infusion until all resolution criteria are met, regardless of glucose level 1, 2. Ketonemia resolves more slowly than hyperglycemia 1, 2.

Step 9: Transition to Subcutaneous Insulin

Administer basal subcutaneous insulin (NPH, detemir, glargine, or degludec) 2-4 hours BEFORE stopping IV insulin infusion to prevent rebound hyperglycemia and recurrent ketoacidosis 1, 2, 3. This overlap period is essential 1, 2.

• Once the patient can eat, start a multiple-dose insulin regimen using short/rapid-acting plus intermediate/long-acting insulin 1, 2.
• For newly diagnosed patients, start total daily insulin dose of approximately 0.5-1.0 units/kg/day 1, 2.
• If the patient remains NPO after DKA resolution, continue IV insulin and fluid replacement, supplementing with subcutaneous regular insulin as needed 1.

---

Special Considerations

Bicarbonate Therapy

Bicarbonate is NOT recommended for DKA patients with pH >6.9-7.0 1, 2, 3. Multiple studies show no difference in resolution of acidosis or time to discharge with bicarbonate use, and it may worsen ketosis, cause hypokalemia, and increase cerebral edema risk 1, 2. Consider bicarbonate only if pH <6.9 after initial fluid resuscitation 2.

Cerebral Edema

Monitor closely for cerebral edema, especially with overly aggressive fluid resuscitation 1, 3. Although more common in children and adolescents, it remains a serious complication in adults 1. Signs include altered mental status, headache, or neurological deterioration 1.

SGLT2 Inhibitors

Discontinue SGLT2 inhibitors immediately and do not restart until 3-4 days after metabolic stability is achieved 1, 2. These medications can precipitate euglycemic DKA 1, 4.

---

Critical Pitfalls to Avoid

• Starting insulin before correcting severe hypokalemia (K⁺ <3.3 mEq/L) can cause life-threatening arrhythmias 1, 2.
• Stopping insulin when glucose falls to 250 mg/dL without adding dextrose leads to recurrent ketoacidosis 1, 2.
• Premature termination of insulin therapy before complete resolution of ketosis causes DKA recurrence 1, 2.
• Inadequate potassium monitoring and replacement is a leading cause of mortality in DKA 1, 2.
• Relying on nitroprusside-based ketone tests misses β-hydroxybutyrate and delays appropriate treatment 1, 2.
• Overly rapid correction of serum osmolality (>3 mOsm/kg/hour) increases cerebral edema risk 1, 2.
• Stopping IV insulin without prior administration of basal subcutaneous insulin causes rebound hyperglycemia and ketoacidosis 1, 2.

---

Discharge Planning

• Identify outpatient diabetes care providers before discharge 1, 2.
• Educate patients on recognition, prevention, and management of DKA, glucose monitoring, insulin administration, and recognition/treatment of hyperglycemia and hypoglycemia 1, 2.
• Ensure appropriate insulin regimen is prescribed with attention to medication access and affordability 1.
• Schedule follow-up appointments prior to discharge 1.